This is a general overview and status of places affected by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus which causes coronavirus disease 2019 (COVID-19) and is responsible for the COVID-19 pandemic. The first human cases of COVID-19 were identified in Wuhan, the capital of the province of Hubei in China in December 2019.
The figures presented are based on reported cases and deaths. While in several high-income countries the ratio of total estimated cases and deaths to reported cases and deaths is low and close to 1, for some countries it may be more than 10 or even more than 100. Implementation of COVID-19 surveillance methods varies widely.
Cases Analysis
Total cases- Total cases are 516,543,980in the world till now.
Total deaths in the world- Total deaths are 6,213,194 .
Total deaths in India-Total deaths are 6,213,194 .
Total deaths in India-Total deaths are 6,213,194 .
India Covid Cases Graph Analysis
Top 5 Countries With Most Covid Cases
Country Total Cases Total Deaths Active Cases Recovered United States 85,716,214 1,031,273 327,567 84,674,895 India 43,155,749 524611 17567 42,613,440 Brazil 30,953,579 666,496 88,765 29,944,585 France 29,479,438 148,129 13,463,708 15,867,601 Germany 26,286,888 139,132 801,345 25,216,200
Covid-19 Vaccine
A COVID‑19 vaccine is a vaccine intended to provide acquired immunity against severe acute respiratory syndrome coronavirus 2 (SARS‑CoV‑2), the virus that causes coronavirus disease 2019 (COVID‑19). Prior to the COVID‑19 pandemic, an established body of knowledge existed about the structure and function of coronaviruses causing diseases like severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS). This knowledge accelerated the development of various vaccine platforms during early 2020. The initial focus of SARS-CoV-2 vaccines was on preventing symptomatic, often severe illness.
The COVID‑19 vaccines are widely credited for their role in reducing the severity and death caused by COVID‑19. Many countries have implemented phased distribution plans that prioritize those at highest risk of complications, such as the elderly, and those at high risk of exposure and transmission, such as healthcare workers.
As of 26 May 2022, 11.81 billion doses of COVID‑19 vaccines have been administered worldwide based on official reports from national public health agencies. By December 2020, more than 10 billion vaccine doses had been preordered by countries, with about half of the doses purchased by high-income countries comprising 14% of the world's population. Despite the extremely rapid development of effective mRNA and viral vector vaccines, worldwide vaccine equity has not been achieved.
